CCM
DSCI

Camber Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Camber Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-497,000
Closed -$5.38M – 46
2013
Q4 		$5.38M Sell
497,000
-453,000
-48% -$5.26M 0.47% 33
2013
Q3 		$11.8M Hold
950,000
– – 1.23% 23
2013
Q2 		$12.7M Buy
+950,000
New +$12.2M 1.3% 23

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Camber Capital Management's DSCI Position: Q1 2014 in Review

Camber Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2014, closing a stake of 497,000 shares — an estimated $5.38M sold.

Camber Capital Management first reported a position in DSCI in Q2 2013 and held it in 3 quarters. The position peaked at $12.7M in Q2 2013. 71 funds tracked by Wall St. Rank hold DSCI as of Q1 2014.

  • Camber Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2014 after selling out during the quarter.
  • Camber Capital Management sold 497,000 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2014, an estimated $5.38M.
  • Camber Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 3 quarters.
  • Camber Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $12.7M in Q2 2013.
  • 71 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2014.

Based on Camber Capital Management's 13F filing for Q1 2014, filed 15 May 2014.